PRMT5 and breast cancer: PRMT5-mediated symmetric dimethylation of KLF5 (an oncogenic factor) at R57 antagonizes GSK3β-mediated KLF5 phosphorylation and Fbw7-mediated KLF5 ubiquitination to promote basal-like breast cancer (BLBC)58.